← Eichor
Study identifier: NCT06700590 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

First-Line Intervention for PTSD - Intensive Treatment

Condition: PTSD - Post Traumatic Stress Disorder  ·  Sponsor: ARQ National Psychotrauma Centre

PhaseNA
Planned participants186
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if an intensive program can treat post-traumatic stress disorder (PTSD) in adults getting treatment for the first time, and whether it has lower societal costs. The main questions it aims to answer are: * Does an intensive program reduce PTSD symptoms? * How expensive is it on a societal level? Researchers will compare the intensive program to the standard weekly treatment to see if the intensive program works to treat PTSD. Participants will: * Get 5 days of intensive treatment in two weeks (with two preparatory and closing sessions), or weekly sessions * Get questionnaires and interviews 5 times in 9 months

This description comes directly from the study's public registry record.

Talk to the study team

Mirjam Mink-Nijdam, PhD  ·  +31(0)20 840 7640  ·  m.mink@centrum45.nl

Bram Kemmere, Msc.  ·  +31(0)20 840 7640  ·  b.kemmere@arq.org

Always discuss trial participation with your own doctor first.

Locations (4)

ARQ IVPDiemen, North Holland, NetherlandsRecruiting
Psychotraumacentrum HaarlemHaarlem, North Holland, NetherlandsRecruiting
Psy-Zo!Groningen, Provincie Groningen, NetherlandsRecruiting
ARQ Centrum'45Oegstgeest, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06700590